TGR (tumor regression grade) in rectal cancer

Pathological features, or TGR, of rectal cancer after preoperative radiochemotherapy:

Source: Dworak O, et al, 1997, cited by Park YJ, Oh BR, Lim SW, Huh JW, Joo JK, Kim YJ, Kim HR. Clinical significance of tumor regression grade in rectal cancer with preoperative chemoradiotherapy. J Korean Soc Coloproctol. 2010 Aug;26(4):279-86. Available at: https://doi.org/10.3393/jksc.2010.26.4.279.

TRG (tumor regression grade) in esophageal carcinoma

Pathological response grading or TRG following neoadjuvant chemoradiation in oesophageal cancer:

Source: Mandard AM, et al., 1994, cited by Gillham CM, Reynolds J, Hollywood D. Predicting the response of localised oesophageal cancer to neo-adjuvant chemoradiation. World J Surg Oncol. 2007 Aug 23;5:97. Available at: https://doi.org/10.1186/1477-7819-5-97.

December 2017 issue of «highlights» from ENLIGHT

Highlights December 2017, from ENLIGHT.

ENLIGHT

The European Network for LIGht ion Hadron Therapy.

Metastasis-directed treatment improves progression-free survival in prostate cancer

Check the Tweet @AmerUrological: https://twitter.com/AmerUrological/status/943111372270964736?s=09

Integração de novas formas de radioterapia na prática clínica (Portuguese) (integration of new forms of radiotherapy in clinical practice)

Interview with the president of SPRO (Portuguese Society of Radiation Oncology), Dr. Lurdes Trigo:

The 5 C's - remember the basics (editing)

From Visually.

Non-small cell lung cancer treatment (r)evolution: ten years of advances and more to come. ecancermedicalscience - The open access journal from the European Institute of Oncology and the OCEI

Non-small cell lung cancer treatment (r)evolution: ten years of advances and more to come. ecancermedicalscience - The open access journal from the European Institute of Oncology and the OCEI

Source: Toschi L, Rossi S, Finocchiaro G, Santoro A. Non-small cell lung cancer treatment (r)evolution: ten years of advances and more to come. ecancermedicalscience. 2017;11. doi:10.3332/ecancer.2017.787.

Source: Toschi L, Rossi S, Finocchiaro G, Santoro A. Non-small cell lung cancer treatment (r)evolution: ten years of advances and more to come. ecancermedicalscience. 2017;11. doi:10.3332/ecancer.2017.787.